Official data from CPSC · FDA · USDA FSIS · NHTSA · Updated hourly
Get alerts
High riskFDAHome & Health

Par Health USA recalls Argatroban Injection, USP, 250 mg/2.5mL

Argatroban Injection 250 mg/2.5 mL (100 mg/mL) vial label
Argatroban Injection 250 mg/2.5 mL (100 mg/mL) vial label Image: FDA
Argatroban Injection 250 mg/2.5 mL (100 mg/mL) vial label 2
Argatroban Injection 250 mg/2.5 mL (100 mg/mL) vial label 2 Image: FDA

What should I do?

Check your medicine against the product and lot details below. If it matches, stop using it, contact your pharmacist or doctor, and return it as directed.

What's the hazard?

Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.

What's affected

Argatroban Injection, USP, 250 mg/2.5mL (100 mg/mL), 2.5 mL x 1 Single Dose Vial, Rx only, Manufactured for: Endo USA, Malvern,PA 19355/Argatroban Injection, 250 mg/2.5mL (100 mg/mL), 2.5 mL x 1 Single Dose Vial, Rx only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 42023-182-01.

Read the official FDA recall announcement ↗

More Home & Health recalls